NCT00404170View on ClinicalTrials.gov

Assessing Imaging as a Tool in Monitoring and Predicting the Progression of Parkinson Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

396

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2014

Conditions
Parkinson Disease
Interventions
DRUG

B-CIT and SPECT imaging

Optional ongoing B-CIT SPECT imaging scans at follow-up visits

Trial Locations (1)

06510

Institute for Neurodegenerative Disorders, New Haven

All Listed Sponsors
collaborator

United States Department of Defense

FED

lead

Institute for Neurodegenerative Disorders

OTHER

NCT00404170 - Assessing Imaging as a Tool in Monitoring and Predicting the Progression of Parkinson Disease | Biotech Hunter | Biotech Hunter